NSC 12407 is primarily investigated for its potential in cancer research due to its ability to interfere with cell proliferation. It has shown promise in preclinical studies as a candidate for inhibiting the growth of certain tumor types by targeting specific cellular pathways involved in cancer progression. Researchers are exploring its efficacy in combination with other therapeutic agents to enhance its anticancer properties. Additionally, NSC 12407 is being studied for its role in understanding molecular mechanisms related to cell cycle regulation, which could provide insights into developing novel treatments for various malignancies. Its application remains largely experimental, focusing on its potential as a chemotherapeutic agent.